These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7905393)

  • 1. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
    Poon GK; Chui YC; McCague R; Lłnning PE; Feng R; Rowlands MG; Jarman M
    Drug Metab Dispos; 1993; 21(6):1119-24. PubMed ID: 7905393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tamoxifen metabolites in human Hep G2 cell line, human liver homogenate, and patients on long-term therapy for breast cancer.
    Poon GK; Walter B; Lønning PE; Horton MN; McCague R
    Drug Metab Dispos; 1995 Mar; 23(3):377-82. PubMed ID: 7628304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
    Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational study of tamoxifen phase I metabolites using chromatographic and spectroscopic analytical techniques.
    Teunissen SF; Rosing H; Seoane MD; Brunsveld L; Schellens JH; Schinkel AH; Beijnen JH
    J Pharm Biomed Anal; 2011 Jun; 55(3):518-26. PubMed ID: 21392921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
    Teunissen SF; Jager NG; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1677-85. PubMed ID: 21543272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomonitoring of urinary tamoxifen and its metabolites from breast cancer patients using nonaqueous capillary electrophoresis with electrospray mass spectrometry.
    Carter SJ; Li XF; Mackey JR; Modi S; Hanson J; Dovichi NJ
    Electrophoresis; 2001 Aug; 22(13):2730-6. PubMed ID: 11545399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of n-hexane metabolites by liquid chromatography/mass spectrometry. 2. Glucuronide-conjugated metabolites in untreated urine samples by electrospray ionization.
    Manini P; Andreoli R; Mutti A; Bergamaschi E; Niessen WM
    Rapid Commun Mass Spectrom; 1998; 12(21):1615-24. PubMed ID: 9807835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of tamoxifen using LC-MS/MS.
    Tchu SM; Lynch KL; Wu AH
    Methods Mol Biol; 2012; 902():211-22. PubMed ID: 22767121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
    Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
    J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 4-hydroxy-N-desmethyltamoxifen as a metabolite of tamoxifen in human bile.
    Lien EA; Solheim E; Kvinnsland S; Ueland PM
    Cancer Res; 1988 Apr; 48(8):2304-8. PubMed ID: 3349495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment.
    Lien EA; Solheim E; Lea OA; Lundgren S; Kvinnsland S; Ueland PM
    Cancer Res; 1989 Apr; 49(8):2175-83. PubMed ID: 2702659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioanalytical methods for determination of tamoxifen and its phase I metabolites: a review.
    Teunissen SF; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
    Anal Chim Acta; 2010 Dec; 683(1):21-37. PubMed ID: 21094378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study.
    Zhu YB; Zhang Q; Zou JJ; Yu CX; Xiao DW
    J Pharm Biomed Anal; 2008 Jan; 46(2):349-55. PubMed ID: 18037598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment.
    Lien EA; Solheim E; Ueland PM
    Cancer Res; 1991 Sep; 51(18):4837-44. PubMed ID: 1893376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours.
    MacCallum J; Cummings J; Dixon JM; Miller WR
    Br J Cancer; 2000 May; 82(10):1629-35. PubMed ID: 10817496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
    Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
    Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of tamoxifen urinary metabolites in rat by ultra-high-performance liquid chromatography time-of-flight mass spectrometry.
    Domínguez-Romero JC; García-Reyes JF; Beneito-Cambra M; Martínez-Romero R; Martinez-Lara E; Del Moral-Leal ML; Molina-Díaz A
    Biomed Chromatogr; 2015 Aug; 29(8):1220-8. PubMed ID: 25611330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry.
    Teunissen SF; Rosing H; Koornstra RH; Linn SC; Schellens JH; Schinkel AH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2519-29. PubMed ID: 19589736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen and its main metabolites serum and tissue concentrations in breast cancer women.
    Furlanut M; Franceschi L; Pasqual E; Bacchetti S; Poz D; Giorda G; Cagol P
    Ther Drug Monit; 2007 Jun; 29(3):349-52. PubMed ID: 17529893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid.
    Sidelmann UG; Christiansen E; Krogh L; Cornett C; Tjørnelund J; Hansen SH
    Drug Metab Dispos; 1997 Jun; 25(6):725-31. PubMed ID: 9193874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.